Get the Stockscreener App
1.96
8.29%
0.15
Pre-market:
1.91
-0.05
-2.55%
Annexon Inc stock is traded at $1.96, with a volume of 3.12M.
It is up +8.29% in the last 24 hours and down -25.76% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$1.81
Open:
$1.76
24h Volume:
3.12M
Relative Volume:
2.17
Market Cap:
$215.03M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.1073
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
-14.22%
1M Performance:
-25.76%
6M Performance:
-69.47%
1Y Performance:
-69.47%
1-Day Range:
$1.73
$2.00
1-Week Range:
$1.73
$2.34
52-Week Range:
$1.73
$7.85
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
1.96 | 215.03M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Here's Why We're Not Too Worried About Annexon's (NASDAQ:ANNX) Cash Burn Situation - Yahoo Finance
135,000 Shares in Annexon, Inc. (NASDAQ:ANNX) Purchased by Swiss National Bank - Defense World
Annexon Inc (NASDAQ: ANNX) Slashes -7.49%: The Most Likely Path Going Forward - Stocks Register
Annexon, Inc. (NASDAQ:ANNX) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Annexon stock hits 52-week low at $2.28 amid market challenges By Investing.com - Investing.com South Africa
Annexon stock hits 52-week low at $2.28 amid market challenges - Investing.com Australia
Bank of New York Mellon Corp Acquires 6,226 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Annexon Inc (NASDAQ: ANNX): Down -60.53% In 2025, Outlook Remains Negative - Stocks Register
Annexon Inc (ANNX) With A Potential Upside Of More Than -460.0% - Stocks Register
Quarterly Metrics: Quick and Current Ratios for Annexon Inc (ANNX) - The Dwinnex
Annexon (ANNX) Projected to Post Earnings on Tuesday - Defense World
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Annexon Strengthens Team with 35,000-Share Stock Option Grant to Key New Hire - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
19,895 Shares in Annexon, Inc. (NASDAQ:ANNX) Acquired by Arizona State Retirement System - Defense World
Wells Fargo Predicts Up to ~440% Rally for These 2 ‘Strong Buy’ Stocks - markets.businessinsider.com
Annexon: Despite Major Catalysts, Stock Is Trading Almost At Cash (NASDAQ:ANNX) - Seeking Alpha
Annexon, Inc. (NASDAQ:ANNX) Given Average Rating of “Buy” by Analysts - Defense World
Rhumbline Advisers Purchases 5,854 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Q1 Earnings Forecast for Annexon Issued By HC Wainwright - Defense World
Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating - TipRanks
Q2 Earnings Estimate for Annexon Issued By HC Wainwright - Defense World
Analysts Set Expectations for Annexon FY2025 Earnings - Defense World
New York State Common Retirement Fund Purchases 20,311 Shares of Annexon, Inc. (NASDAQ:ANNX) - Defense World
Potential Price Increase for Annexon Inc (ANNX) After Recent Insider Activity - Knox Daily
Annexon stock price target cut to $20 at H.C. Wainwright By Investing.com - Investing.com Canada
Annexon (NASDAQ:ANNX) Given “Buy” Rating at Needham & Company LLC - Defense World
Gaining Ground: Annexon Inc (ANNX) Closes Lower at 2.39, Down -9.47 - The Dwinnex
Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating - TipRanks
Annexon Biosciences Reports Strong Progress in 2024 - MSN
Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones - The Manila Times
Annexon reports Q4 EPS (33c), consensus (29c) - TipRanks
Annexon Reports Fourth Quarter and Year-End 2024 Financial - GlobeNewswire
Can Annexon's $312M War Chest Fuel Its Breakthrough Treatments Through 2026? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges - Investing.com Australia
Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
What Will Annexon Reveal at the TD Cowen Healthcare Conference Next Week? - StockTitan
Annexon stock hits 52-week low at $2.63 amid market challenges By Investing.com - Investing.com South Africa
Annexon stock hits 52-week low at $3.04 amid market challenges - MSN
Annexon, Inc. (NASDAQ:ANNX) CEO Sells $14,811.95 in Stock - MarketBeat
Annexon executive sells shares worth $16,379 By Investing.com - Investing.com South Africa
Annexon EVP Ted Yednock sells $24,283 in stock - Investing.com India
Annexon chief medical officer sells $16,342 in common stock By Investing.com - Investing.com South Africa
Annexon chief medical officer sells $16,342 in common stock - Investing.com
Annexon chief business officer sells $19,523 in company stock By Investing.com - Investing.com Australia
Annexon executive sells shares worth $16,379 - Investing.com
Annexon chief business officer sells $19,523 in company stock - Investing.com
Annexon CFO Jennifer Lew sells shares worth $20,183 By Investing.com - Investing.com South Africa
Annexon CFO Jennifer Lew sells shares worth $20,183 - Investing.com
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):